Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). THC Therapeutics's share price for the quarter that ended in Jul. 2024 was $0.0006. THC Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Jul. 2024 was 38.87 Mil. Therefore, THC Therapeutics's market cap for the quarter that ended in Jul. 2024 was $0.02 Mil.
THC Therapeutics's quarterly market cap
increased
from Jan. 2024 ($0.12 Mil) to Apr. 2024 ($0.13 Mil) but then
declined
from Apr. 2024 ($0.13 Mil) to Jul. 2024 ($0.02 Mil).
THC Therapeutics's annual market cap
declined
from Jul. 2022 ($0.88 Mil) to Jul. 2023 ($0.10 Mil) and
declined
from Jul. 2023 ($0.10 Mil) to Jul. 2024 ($0.02 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. THC Therapeutics's Enterprise Value for Today is $0.76 Mil.
THC Therapeutics (OTCPK:THCT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
THC Therapeutics Market Cap Related Terms
THC Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for THC Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
THC Therapeutics Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where THC Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
THC Therapeutics's Market Cap for the fiscal year that ended in Jul. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
THC Therapeutics (THCT) has a Market Cap of $0.02 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on THC Therapeutics and its competitors.
Is THC Therapeutics' Market Cap too high?
THC Therapeutics' current Market Cap is $0.02 Mil. The Drug Manufacturers industry median Market Cap is 210.64. THC Therapeutics' value of $0.02 Mil is 100% below this industry median.
How does THC Therapeutics' Market Cap compare to ZTS and UTHR?
THC Therapeutics' Market Cap of $0.02 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 210.64. THC Therapeutics' value of $0.02 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 210.64, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. THC Therapeutics's current Market Cap of $0.02 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on THC Therapeutics and its competitors. For the Drug Manufacturers industry, the median Market Cap is 210.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. THC Therapeutics's current Market Cap is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current Market Cap of $0.02 Mil. The current Market Cap is $0.02 Mil and 100% below the Drug Manufacturers industry median of 210.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For THC Therapeutics (THCT), the current Market Cap is $0.02 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THCT has been successfully added to your 
